The management of smoldering multiple myeloma (MM) is undergoing a significant transformation, driven by growing evidence that early intervention can meaningfully delay progression to active disease.

Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope every viewer, near or far, takes home.

Bidisha Mandal, PhD, a professor at Washington State University, continued the conversation about her study, “Telehealth for Primary and Preventive Care Among Food-Insecure Individuals,” recently ...

Published in JAMA Network Open, the study found that women with breast cancer living in Medicaid expansion states had a 4.8% lower risk of death compared with those in nonexpansion states. Researchers ...

From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope every viewer, near or far, takes home.

The federal IACC, created in 2006, provides nonbinding guidance that helps align national autism research and services and supports coordination of approximately $2 billion in annual government ...

Glaucoma medication adherence and glaucoma-related distress were both improved when patients used the Support, Educate, Empower (SEE) glaucoma coaching program vs the standard written education ...

Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...

These results suggest that ruxolitinib cream offers high levels of clinical efficacy, including deep and rapid responses, ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, ...

Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...